← Back to Search

Procedure

Radiofrequency Ablation for Thyroid Nodules

N/A
Recruiting
Led By Kim O Learned
Research Sponsored by M.D. Anderson Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Patient is able to understand and give consent to participation in the study
Patient is older than 18 years, is not a surgical candidate or refuses to have surgery
Must not have
Allergies to medications for anesthesia
Extra-thyroidal invasion of PTC OR local nodal/distant systemic metastatic disease
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline up to 12 months
Awards & highlights
No Placebo-Only Group

Summary

This trial studies radiofrequency ablation to treat patients with benign or low-risk thyroid nodules. The goal is to learn if it is as effective as surgery and if it has a better recovery response.

Who is the study for?
This trial is for adults over 18 with benign thyroid nodules or low-risk thyroid cancer who have symptoms, want treatment but can't or won't have surgery. They must be fit for local anesthesia, able to consent, and the nodule must be visible on ultrasound and confirmed benign or low-risk cancer without metastasis.
What is being tested?
The study tests radiofrequency ablation (RFA), a less invasive procedure using electric current to heat and destroy tumor cells. It's compared to standard surgery in terms of effectiveness and recovery for treating thyroid nodules or small recurrent cancers.
What are the potential side effects?
Potential side effects of RFA may include pain at the site of treatment, swelling, bruising, infection risk at the needle insertion point, temporary voice changes due to nerve irritation near the thyroid gland.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I understand and agree to participate in the study.
Select...
I am over 18 and cannot or will not have surgery.
Select...
I have a single thyroid nodule or a dominant one in a multinodular goiter.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I am allergic to some anesthesia medications.
Select...
My thyroid cancer has spread beyond the thyroid or to other parts of my body.
Select...
My targeted nodule is close to major blood vessels or important nerves.
Select...
My thyroid cancer is of an aggressive type, confirmed by a team of specialists.
Select...
I have had radiation therapy to my neck.
Select...
I have a heart rhythm problem or a device like a pacemaker.
Select...
My thyroid nodules are overactive, confirmed by tests.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline up to 12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline up to 12 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Changes in thyroid nodule size
Secondary study objectives
Cost of ultrasound-guided radiofrequency ablation (RFA)
Sonographic features of nodules
Treatment response that affect quality of life

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Treatment (RFA)Experimental Treatment2 Interventions
Patients undergo ultrasound guided RFA over 1-2 hours.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Radiofrequency Ablation
2013
Completed Phase 4
~1120

Find a Location

Who is running the clinical trial?

M.D. Anderson Cancer CenterLead Sponsor
3,067 Previous Clinical Trials
1,802,509 Total Patients Enrolled
Kim O LearnedPrincipal InvestigatorM.D. Anderson Cancer Center

Media Library

Radiofrequency Ablation (Procedure) Clinical Trial Eligibility Overview. Trial Name: NCT05003856 — N/A
Thyroid Cancer Research Study Groups: Treatment (RFA)
Thyroid Cancer Clinical Trial 2023: Radiofrequency Ablation Highlights & Side Effects. Trial Name: NCT05003856 — N/A
Radiofrequency Ablation (Procedure) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05003856 — N/A
~21 spots leftby Jun 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top